Patrick Soon-Shiong was born on July 29,1952 and is an American transplant surgeon, billionaire businessman, bioscientist, and media proprietor.
34 Facts About Patrick Soon-Shiong
2.
Patrick Soon-Shiong is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.
3.
Patrick Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.
4.
Patrick Soon-Shiong has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the Los Angeles Times and The San Diego Union-Tribune.
5.
Patrick Soon-Shiong has committed to the Giving Pledge and has pledged to give away at least half of his wealth to philanthropy.
6.
Patrick Soon-Shiong was born in Port Elizabeth, Union of South Africa, to Chinese immigrant parents who fled from China during the Japanese occupation in World War II.
7.
Patrick Soon-Shiong's parents were Hakka originally from Meixian District in Guangdong province.
8.
Patrick Soon-Shiong completed his medical internship at Johannesburg's General Hospital.
9.
Patrick Soon-Shiong then studied at the University of British Columbia, where he earned a master's degree in 1979, with research awards from the American College of Surgeons, the Royal College of Physicians and Surgeons of Canada, and the American Association of Academic Surgery.
10.
Patrick Soon-Shiong moved to the United States and began surgical training at University of California, Los Angeles, and became a board-certified surgeon in 1984.
11.
Patrick Soon-Shiong is a Fellow of the Royal College of Surgeons and a Fellow of the American College of Surgeons.
12.
Patrick Soon-Shiong joined UCLA Medical School in 1983 and served on that faculty until 1991, as a transplant surgeon.
13.
Patrick Soon-Shiong served as a visiting professor at Imperial College, London, in 2011.
14.
Patrick Soon-Shiong purchased Fujisawa, which sold injectable generic drugs, in 1998.
15.
Patrick Soon-Shiong used its revenues to develop Abraxane, which took an existing chemotherapy drug, Taxol, and wrapped it in protein that made it easier to deliver to tumors.
16.
Patrick Soon-Shiong was able to quickly move it through the regulatory process and made his fortune with this medicine.
17.
Patrick Soon-Shiong later founded Abraxis BioScience, a company he sold to Celgene in 2010 in a cash-and-stock deal valued at over $3 billion.
18.
Patrick Soon-Shiong founded NantHealth in 2007 to provide fiber-optic, cloud-based data infrastructure to share healthcare information.
19.
In October 2012, Patrick Soon-Shiong announced that NantHealth's supercomputer-based system and network were able to analyze the genetic data from a tumor sample in 47 seconds and transfer the data in 18 seconds.
20.
Patrick Soon-Shiong stated that NantWorks' vision for the future of cancer treatment was a convergence of multiple technologies that included diagnostics, supercomputing, network modeling of sharing data on tumor genes and personalized cocktails of cancer drugs in multi-target attacks, to achieve a sustained disease-free state.
21.
In 2010, with Arizona State University and the University of Arizona, Patrick Soon-Shiong founded the Healthcare Transformation Institute, which he dubs a "do-tank".
22.
In July 2015, Patrick Soon-Shiong initiated an IPO for NantKwest that represented the highest value biotech IPO in history, at a market value of $2.6 billion.
23.
Patrick Soon-Shiong is a member of the Berggruen Institute's 21st Century Council.
24.
In early 2016, Patrick Soon-Shiong launched the National Immunotherapy Coalition to encourage rival pharmaceutical companies to work together to test combinations of cancer-fighting drugs.
25.
Patrick Soon-Shiong has met numerous times with former vice president and current US president Joe Biden to discuss more ambitious approaches to fighting cancer, including conducting genomic sequencing of 100,000 patients to create a massive database of potential genetic factors.
26.
In May 2017, Patrick Soon-Shiong was appointed by House Speaker Paul Ryan to the Health Information Technology Advisory Committee, a committee established by the 21st Century Cures Act.
27.
In early 2021, Patrick Soon-Shiong merged a publicly traded company NantKwest with a privately held entity ImmunityBio.
28.
In December 2021, Dr Patrick Soon-Shiong shared pre-clinical results of giving two different vaccine platforms and showed beneficial T cell levels using an adenovirus and mRNA technology.
29.
In January 2022, Patrick Soon-Shiong opened a new manufacturing facility and campus in Cape Town, South Africa with President Ramaphosa.
30.
In 2013, Patrick Soon-Shiong became an early investor in Zoom, a video conferencing company.
31.
In September 2014, NantWorks LLC, a company headed by Patrick Soon-Shiong, invested $2.5 million in AccuRadio.
32.
In 2019, Patrick Soon-Shiong became an investor in a graphene based technology company in Europe called Directa Plus.
33.
In 2021, Patrick Soon-Shiong announced a new investment of $29 million in a biorenewables company called NantRenewables in SeaPoint, Savannah, Georgia.
34.
In 2022, Patrick Soon-Shiong invested in Sienza, a lithium battery company in Pasadena, California.